B. al Wakeel - 06 Jul 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Financial Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
06 Jul 2023
Net transactions value
-$16,852
Form type
4
Filing time
07 Jul 2023, 16:06:57 UTC
Previous filing
23 Jun 2023
Next filing
13 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Sale $16,852 -9,617 -2.7% $1.75 346,102 06 Jul 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
F2 The weighted average sale price for the transaction reported was $1.7523, and the range of prices were between $1.65 and $1.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.